The aim of the present study was to identify changes in gene expression profiles induced by PPARγ and PPARα/γ agonists in human hepatocytes from several donors and in differentiated human hepatoma HepaRG cells using a whole genome transcriptomic approach. The gene discussed is PPARG; the disease is hepatocellular carcinoma.